ArticleJournal for immunotherapy of cancer2025

Pharmacological and structural characterization of vibostolimab, a novel anti-TIGIT blocking antibody for cancer immunotherapy.

Thierry O Fischmann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.